• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌复发:多中心发生还是肝内转移?基于病理学的观点

Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology.

作者信息

Nakashima O, Kojiro M

机构信息

Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0067, Japan.

出版信息

J Hepatobiliary Pancreat Surg. 2001;8(5):404-9. doi: 10.1007/s005340100001.

DOI:10.1007/s005340100001
PMID:11702248
Abstract

Recurrence after successful surgical or nonsurgical treatment of hepatocellular carcinoma (HCC) is caused either by intrahepatic metastasis or by metachronously multicentric occurrence. Intrahepatic metastasis is a major cause of recurrence of advanced HCCs with varying degrees of vascular invasion, and multicentric occurrence is a frequent cause of recurrence in small HCCs with no obvious vascular invasion. It is estimated that at least 20% of small HCCs have a high probability of recurrence due to multicentric occurrence, based on the finding that adenomatous hyperplasia (AH) and/or atypical adenomatous hyperplasia (AAH), which are considered premalignant lesions, are found in the vicinity of resected small HCCs with liver cirrhosis. However, because neither AH nor AAH occur in HCC cases without liver cirrhosis, most recurrence of HCC in noncirrhotic liver is considered to be due to intrahepatic metastasis or to de novo hepatocarcinogenesis. In a survey of autopsy cases of liver cirrhosis with small HCC, smaller HCC nodules were found in other liver slices in 50% of cases, and it is estimated that approximately 50% of HCC is already multicentric in the early stage.

摘要

肝细胞癌(HCC)经手术或非手术成功治疗后的复发,要么是由肝内转移引起,要么是由异时多中心发生所致。肝内转移是伴有不同程度血管侵犯的晚期HCC复发的主要原因,而多中心发生则是无明显血管侵犯的小HCC复发的常见原因。基于在切除的伴有肝硬化的小HCC附近发现被认为是癌前病变的腺瘤样增生(AH)和/或非典型腺瘤样增生(AAH)这一发现,估计至少20%的小HCC因多中心发生而有较高的复发概率。然而,由于在无肝硬化的HCC病例中既不发生AH也不发生AAH,因此非肝硬化肝脏中HCC的大多数复发被认为是由于肝内转移或新发肝癌形成。在一项对伴有小HCC的肝硬化尸检病例的调查中,50%的病例在其他肝切片中发现了更小的HCC结节,据估计,大约50%的HCC在早期就已经是多中心的了。

相似文献

1
Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology.肝细胞癌复发:多中心发生还是肝内转移?基于病理学的观点
J Hepatobiliary Pancreat Surg. 2001;8(5):404-9. doi: 10.1007/s005340100001.
2
[Clinicopathological significance of adenomatous hyperplasia of the liver].[肝脏腺瘤样增生的临床病理意义]
Nihon Rinsho. 1994 Jan;52(1):75-9.
3
Pathological study on multicentric occurrence of hepatocellular carcinoma.肝细胞癌多中心发生的病理学研究
Kurume Med J. 2005;52(4):133-8. doi: 10.2739/kurumemedj.52.133.
4
Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study.非典型腺瘤样增生(临界性肝细胞病变)手术切除后肝硬化肝脏中肝细胞癌的频繁发生:一项随访研究
Am J Gastroenterol. 1994 Jun;89(6):903-8.
5
Postoperative recurrence pattern and prognosis of patients with hepatocellular carcinoma, with particular reference to the hepatitis viral infection status.肝细胞癌患者的术后复发模式和预后,特别提及肝炎病毒感染状态。
Liver Int. 2014 May;34(5):802-13. doi: 10.1111/liv.12447. Epub 2014 Jan 24.
6
A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.对209例经尸检的连续性肝硬化肝脏中肝腺瘤样增生的临床病理研究。
Cancer. 1993 Sep 1;72(5):1551-6. doi: 10.1002/1097-0142(19930901)72:5<1551::aid-cncr2820720511>3.0.co;2-q.
7
Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C.丙型肝炎患者肝细胞癌多中心发生与非癌性肝组织组织学之间的关系
Jpn J Cancer Res. 1999 Oct;90(10):1076-80. doi: 10.1111/j.1349-7006.1999.tb00680.x.
8
Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.乙型肝炎和丙型肝炎相关肝细胞癌手术治疗效果的差异:单一大西洋彼岸中心的回顾性分析。
Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917.
9
Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma.复发性和原发性肝细胞癌多中心起源及肝内转移的克隆性分析
J Gastrointest Surg. 2008 Sep;12(9):1540-7. doi: 10.1007/s11605-008-0591-y. Epub 2008 Jul 16.
10
Multicentric occurrence of hepatocellular carcinoma: diagnosis and clinical significance.肝细胞癌的多中心发生:诊断及临床意义
J Hepatobiliary Pancreat Surg. 2001;8(5):435-40. doi: 10.1007/s005340100006.

引用本文的文献

1
Tumor size larger than 6.5 cm and microvascular invasion are comparable prognosticators for hepatocellular carcinoma: a multi-institutional observational study.肿瘤大小大于6.5厘米和微血管侵犯是肝细胞癌相当的预后因素:一项多机构观察性研究。
Clin Transl Oncol. 2025 Jul 10. doi: 10.1007/s12094-025-03981-3.
2
Exploration of heterogeneity and recurrence signatures in hepatocellular carcinoma.肝细胞癌中异质性和复发特征的探索。
Mol Oncol. 2025 Aug;19(8):2388-2411. doi: 10.1002/1878-0261.70012. Epub 2025 Feb 28.
3
Deficiency of SIAH1 promotes the formation of filopodia by increasing the accumulation of FASN in liver cancer.
SIAH1 缺乏通过增加 FASN 在肝癌中的积累促进了伪足的形成。
Cell Death Dis. 2024 Jul 29;15(7):537. doi: 10.1038/s41419-024-06929-7.
4
Impact of Liver Fibrosis Severity on Oncological Prognosis in Hepatocellular Carcinoma.肝纤维化严重程度对肝细胞癌肿瘤学预后的影响
Liver Cancer. 2023 Oct 31;13(2):150-160. doi: 10.1159/000533857. eCollection 2024 Apr.
5
Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence.肝切除术后复发性肝细胞癌的手术策略:当前证据综述
Cancers (Basel). 2023 Jan 13;15(2):508. doi: 10.3390/cancers15020508.
6
Circulating HOTAIR potentially predicts hepatocellular carcinoma in cirrhotic liver and prefigures the tumor stage.循环中的HOTAIR可能预测肝硬化肝脏中的肝细胞癌并预示肿瘤分期。
Clin Exp Hepatol. 2022 Jun;8(2):139-146. doi: 10.5114/ceh.2022.116820. Epub 2022 Jun 2.
7
LI-RADS Classification and Outcomes of Hepatocellular Carcinoma Treated With Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.经动脉化疗栓塞联合射频消融治疗肝细胞癌的LI-RADS分类及疗效
Cancer Diagn Progn. 2022 Jul 3;2(4):471-481. doi: 10.21873/cdp.10130. eCollection 2022 Jul-Aug.
8
ARID1A expression in hepatocellular carcinoma and relation to tumor recurrence after microwave ablation.ARID1A在肝细胞癌中的表达及其与微波消融后肿瘤复发的关系。
Clin Exp Hepatol. 2022 Mar;8(1):49-59. doi: 10.5114/ceh.2022.114172. Epub 2022 Mar 23.
9
Clinical characteristics and surgical treatments of primary hepatic angiosarcoma.原发性肝血管肉瘤的临床特征及外科治疗
BMC Gastroenterol. 2021 Apr 7;21(1):156. doi: 10.1186/s12876-021-01743-3.
10
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.2018 韩国肝癌协会-韩国国家癌症中心肝细胞癌管理实践指南。
Korean J Radiol. 2019 Jul;20(7):1042-1113. doi: 10.3348/kjr.2019.0140.